Milica Selaković

Dr. Milica Selaković

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MSMilica Selaković
Milica Selaković
DODejan Miloš Opsenica
Dejan Miloš Opsenica
JBJames C. Burnett
James C. Burnett
LGLaura Gomba
Laura Gomba
JNJonathan E. Nuss
Jonathan E. Nuss
BSBogdan Solaja
Bogdan Solaja
Significantly more potent second generation 4-amino-7-chloroquinoline (4,7-ACQ) based inhibitors of the botulinum neurotoxin serotype A (BoNT/A) light chain were synthesized. Introducing an amino group at the C(3) position of the cholate component markedly increased potency (IC50 values for such derivatives ranged from 0.81 to 2.27 μM). Two additional subclasses were prepared: bis(steroidal)-4,7-ACQ derivatives and bis(4,7-ACQ)cholate derivatives; both classes provided inhibitors with nanomolar-range potencies (e.g., the Ki of compound 67 is 0.10 μM). During BoNT/A challenge using primary neurons, select derivatives protected SNAP-25 by up to 89%. Docking simulations were performed to rationalize the compounds’ in vitro potencies. In addition to specific residue contacts, coordination of the enzyme’s catalytic zinc and expulsion of the enzyme’s catalytic water were a consistent theme. With respect to antimalarial activity, the compounds provided better IC90 activities against chloroquine resistant (CQR) malaria than CQ, and seven compounds were more active than mefloquine against CQR strain W2.

24 February 2017 in Molecules
Verified
Journal Article
Open access
PDF file
JKJelena Konstantinović
Jelena Konstantinović
MSMilica Selaković
Milica Selaković
JSJelena Dragiša Srbljanović
Jelena Dragiša Srbljanović
ODOlgica Djurkovic-Djakovic
Olgica Djurkovic-Djakovic
KBKatarina Bogojević
Katarina Bogojević
BSBogdan Solaja
Bogdan Solaja
Malaria is a severe and life-threatening disease caused by Plasmodium parasites that are spread to humans through bites of infected Anopheles mosquitoes. Here, we report on the efficacy of aminoquinolines coupled to benzothiophene and thiophene rings in inhibiting Plasmodium falciparum parasite growth. Synthesized compounds were evaluated for their antimalarial activity and toxicity, in vitro and in mice. Benzothiophenes presented in this paper showed improved activities against a chloroquine susceptible (CQS) strain, with potencies of IC50 = 6 nM, and cured 5/5 Plasmodium berghei infected mice when dosed orally at 160 mg/kg/day × 3 days. In the benzothiophene series, the examined antiplasmodials were more active against the CQS strain D6, than against strains chloroquine resistant (CQR) W2 and multidrug-resistant (MDR) TM91C235. For the thiophene series, a very interesting feature was revealed: hypersensitivity to the CQR strains, resistance index (RI) of <1. This is in sharp contrast to chloroquine, indicating that further development of the series would provide us with more potent antimalarials against CQR strains.

1 September 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMilica Selaković
Milica Selaković
MMMarija Mojsin
Marija Mojsin
MSMilena Stevanovic
Milena Stevanovic
Igor OpsenicaIgor Opsenica
Igor Opsenica
TSTatjana Srdic-Rajic
Tatjana Srdic-Rajic
BSBogdan Solaja
Bogdan Solaja

4 May 2018 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JKJelena Konstantinović
Jelena Konstantinović
MSMilica Selaković
Milica Selaković
SOStefania Orsini
Stefania Orsini
KBKatarina Bogojević
Katarina Bogojević
SDSarah D'Alessandro
Sarah D'Alessandro
BSBogdan Solaja
Bogdan Solaja

6 February 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
JKJelena Konstantinović
Jelena Konstantinović
EKErkan Kiris
Erkan Kiris
KKKrishna P. Kota
Krishna P. Kota
JKJohanny Kugelman-Tonos
Johanny Kugelman-Tonos
MSMilica Selaković
Milica Selaković
BSBogdan Solaja
Bogdan Solaja
The synthesis and inhibitory potencies against botulinum neurotoxin serotype A light chain (BoNT/A LC) using in vitro HPLC based enzymatic assay for various steroidal, benzothiophene, thiophene, and adamantane 4-aminoquinoline derivatives are described. In addition, the compounds were evaluated for the activity against BoNT/A holotoxin in mouse embryonic stem cell derived motor neurons. Steroidal derivative 16 showed remarkable protection (up to 89% of uncleaved SNAP-25) even when administered 30 min postintoxication. This appears to be the first example of LC inhibitors antagonizing BoNT intoxication in mouse embryonic stem cell derived motor neurons (mES-MNs) in a postexposure model. Oral administration of 16 was well tolerated in the mouse up to 600 mg/kg, q.d. Although adequate unbound drug levels were not achieved at this dose, the favorable in vitro ADMET results strongly support further work in this series.